Article Versions Notes

Vicente-Pascual M, Gómez-Aguado I, Rodríguez-Castejón J, Rodríguez-Gascón A, Muntoni E, Battaglia L, del Pozo-Rodríguez A, Solinís Aspiazu MÁ. Topical Administration of SLN-Based Gene Therapy for the Treatment of Corneal Inflammation by De Novo IL-10 Production. Pharmaceutics. 2020; 12(6):584. https://doi.org/10.3390/pharmaceutics12060584

Vicente-Pascual, Mónica, Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Alicia Rodríguez-Gascón, Elisabetta Muntoni, Luigi Battaglia, Ana del Pozo-Rodríguez, and María Ángeles Solinís Aspiazu. 2020. "Topical Administration of SLN-Based Gene Therapy for the Treatment of Corneal Inflammation by De Novo IL-10 Production" Pharmaceutics 12, no. 6: 584. https://doi.org/10.3390/pharmaceutics12060584

Vicente-Pascual, M., Gómez-Aguado, I., Rodríguez-Castejón, J., Rodríguez-Gascón, A., Muntoni, E., Battaglia, L., del Pozo-Rodríguez, A., & Solinís Aspiazu, M. Á. (2020). Topical Administration of SLN-Based Gene Therapy for the Treatment of Corneal Inflammation by De Novo IL-10 Production. Pharmaceutics, 12(6), 584. https://doi.org/10.3390/pharmaceutics12060584